UMIN ID: C000000203
Registered date:13/09/2005
Prevention of hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis by pegylated IFN-alpha-2a after surgical resection or radiofrequency ablation
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | chronic hepatitis C,cirrhosis,hepatocellular carcinoma |
Date of first enrollment | 2003/06/01 |
Target sample size | 100 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | PEG-IFN-alpha2a no treatment |
Outcome(s)
Primary Outcome | Prevention of hepatocellular carcinoma |
---|---|
Secondary Outcome | HCV-RNA,ALT,fibrosis |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | ANC<750/mm3,Plt<50,000/mm3 Child-Pugh B,C |
Related Information
Primary Sponsor | Gunma Liver Study Group |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Gunma Liver Study Group |
Secondary ID(s) |
Contact
public contact | |
Name | Ken Sato |
Address | 3-39-22 Showa, Maebashi, Gunma 371-8511, Japan Japan |
Telephone | 027-220-8127 |
satoken@gunma-u.ac.jp | |
Affiliation | Gunma University Graduate School of Medicine Department of Medicine and Molecular Science |
scientific contact | |
Name | Ken Sato |
Address | 3-39-22 Showa, Maebashi, Gunma 371-8511, Japan Japan |
Telephone | 027-220-8127 |
satoken@gunma-u.ac.jp | |
Affiliation | Gunma University Graduate School of Medicine Department of Medicine and Molecular Science |